Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation By NICE For The Prevention Of Cisplatin-Induced Hearing Loss In England And Wales

(MENAFN - GlobeNewsWire - Nasdaq) ~ PEDMARQSI– (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ...

By: menafn